Pediatric Deprtmemt, Alsabah hospital
Kuwait City, Kuwait
NCT Number: NCT03618147
* Background/Rationale: Epidemiological data about Primary Immunodeficiency Disorders (PIDD) in Kuwait is needed to better understand peculiarities and to compare them with other regions and ethnicity. * Study hypothesis: PIDD is relatively common in Kuwait compared to populations from different geographic areas. The distribution of PIDD in Kuwait is different from other geographic areas with more severe forms being more frequent. * Brief inclusion and exclusion criteria of study participants: PIDD patients presented at different clinics/hospital in Kuwait. Patients with secondary immunodeficiencies (drug induced, virus induced, and immunodeficiency associated with metabolic disorders... ect), will be excluded * Estimated sample size of the study: All patients who were registered in KNPIDR since 2004 will be included in the study along with the new patients who will be recruited during the study period. * Primary objectives:
* Determine the prevalence and frequency of different PIDD in Kuwait * Identify clinical presentation patterns for PIDD in Kuwait * Identify natural history of PIDD in Kuwait * Help to asses epidemiology of PIDD in Kuwait * Determine particularities about PIDD affecting the population in Kuwait * Determine the health impact of PIDD in Kuwait * Development of strategies to improve the care and the quality of life of patients with PIDD
Looking for future studies?
Notify MeAll sexes
Observational
Kuwait City, Kuwait
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 15 years
Time frame: 15 years
Kuwait Society for Allergy and Clinical Immunology
Other
Kuwait National Primary Immunodeficiency Registry (KNPIDR)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03414528
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Zurich, Switzerland
View Trial DetailsNCT03939533
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Scottsdale, Arizona, United States
View Trial DetailsNCT02888535
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Caen, France
View Trial DetailsNCT03069079
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
London, Greater London, United Kingdom
View Trial Details